Pivotal Study of the NanoKnife System for the Ablation of Prostate Tissue
NCT: NCT04972097 · COMPLETED
Brief Summary
Pivotal study to evaluate the use of the NanoKnife System as a focal therapy option for prostate cancer patients. This study will assess the safety and effectiveness of the device when used to ablate prostate tissue in intermediate-risk prostate cancer patients.
Frequently Asked Questions
What is Pivotal Study of the NanoKnife System for the Ablation of Prostate Tissue?
Pivotal Study of the NanoKnife System for the Ablation of Prostate Tissue is a clinical trial registered under NCT04972097. Current status: COMPLETED.
What is the status of NCT04972097?
The current status of NCT04972097 (Pivotal Study of the NanoKnife System for the Ablation of Prostate Tissue) is: COMPLETED.
When did Pivotal Study of the NanoKnife System for the Ablation of Prostate Tissue start?
Pivotal Study of the NanoKnife System for the Ablation of Prostate Tissue started on 2022-03-29.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.